Boundless Bio (BOLD) 8-K Summary (11/05/2025)

Boundless Bio filed this Form 8-K to announce the release of its financial results for the quarter ended September 30, 2025.

• Material Information Location: Specific financial performance details, operational metrics, and forward-looking guidance are contained only within the attached press release (Exhibit 99.1).
• Ticker: BOLD (Nasdaq).
• The registrant confirms its status as an Emerging Growth Company.

Investors must review Exhibit 99.1 for performance data, as Item 2.02 only reports the furnishing of these